Matthew Caufield's Stock Ratings

HC Wainwright & Co. Analyst

Matthew Caufield is an analyst at HC Wainwright & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/17/2024

Overall Average Return

-21.9%

Smart Score

39.4%

Overall Average Return Percentile

10th

Number of Ratings

68
Buy NowGet Alert
05/16/2024EYENBuy Now
Eyenovia
$0.841330.27% → $12ReiteratesBuy → BuyGet Alert
05/15/2024OPTNBuy Now
OptiNose
$1.28290.47% → $5ReiteratesBuy → BuyGet Alert
05/13/2024OCUPBuy Now
Ocuphire Pharma
$1.711069.59% → $20ReiteratesBuy → BuyGet Alert
05/13/2024FDMTBuy Now
4D Molecular Therapeutics
$24.8944.67% → $36ReiteratesBuy → BuyGet Alert
05/10/2024PHATBuy Now
Phathom Pharmaceuticals
$10.48167.18% → $28ReiteratesBuy → BuyGet Alert
05/10/2024HLVXBuy Now
HilleVax
$15.7378% → $28ReiteratesBuy → BuyGet Alert
05/10/2024ADVMBuy Now
Adverum Biotechnologies
$8.21265.41% → $30ReiteratesBuy → BuyGet Alert
05/07/2024LYRABuy Now
Lyra Therapeutics
$0.37435.76% → $2DowngradeBuy → NeutralGet Alert
05/06/2024ALDXBuy Now
Aldeyra Therapeutics
$4.10143.9% → $10ReiteratesBuy → BuyGet Alert
05/01/2024LYRABuy Now
Lyra Therapeutics
$0.373114.57% → $12ReiteratesBuy → BuyGet Alert
04/30/2024ADVMBuy Now
Adverum Biotechnologies
$8.21265.41% → $30Initiates → BuyGet Alert
04/29/2024OPTNBuy Now
OptiNose
$1.28290.47% → $5ReiteratesBuy → BuyGet Alert
04/02/2024ALDXBuy Now
Aldeyra Therapeutics
$4.10143.9% → $10ReinstatesBuy → BuyGet Alert
03/22/2024LYRABuy Now
Lyra Therapeutics
$0.373114.57% → $12ReiteratesBuy → BuyGet Alert
03/21/2024HLVXBuy Now
HilleVax
$15.7378% → $28ReiteratesBuy → BuyGet Alert
03/19/2024EYENBuy Now
Eyenovia
$0.841330.27% → $12ReiteratesBuy → BuyGet Alert
03/18/2024OPTNBuy Now
OptiNose
$1.28290.47% → $5ReiteratesBuy → BuyGet Alert
03/11/2024OCUPBuy Now
Ocuphire Pharma
$1.711069.59% → $20ReiteratesBuy → BuyGet Alert
03/11/2024OPTNBuy Now
OptiNose
$1.28290.47% → $5Initiates → BuyGet Alert
03/08/2024PHATBuy Now
Phathom Pharmaceuticals
$10.48167.18% → $28ReiteratesBuy → BuyGet Alert
03/06/2024EYENBuy Now
Eyenovia
$0.841330.27% → $12ReiteratesBuy → BuyGet Alert
03/01/2024FDMTBuy Now
4D Molecular Therapeutics
$24.8944.67% → $36ReiteratesBuy → BuyGet Alert
12/13/2023HLVXBuy Now
HilleVax
$15.7378% → $28Initiates → BuyGet Alert
11/14/2023OCUPBuy Now
Ocuphire Pharma
$1.711069.59% → $20ReiteratesBuy → BuyGet Alert
11/14/2023UBXBuy Now
Unity Biotechnology
$1.48575.31% → $10ReiteratesBuy → BuyGet Alert
11/14/2023EYENBuy Now
Eyenovia
$0.841330.27% → $12ReiteratesBuy → BuyGet Alert
10/02/2023LYRABuy Now
Lyra Therapeutics
$0.373114.57% → $12ReiteratesBuy → BuyGet Alert
08/31/2023LYRABuy Now
Lyra Therapeutics
$0.373114.57% → $12Initiates → BuyGet Alert
08/22/2023FNBuy Now
Fabrinet
$235.15-88.09% → $28ReiteratesBuy → BuyGet Alert
08/18/2023EYENBuy Now
Eyenovia
$0.841330.27% → $12ReiteratesBuy → BuyGet Alert